Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Panic Disorder
NCT00438971Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of duloxetine in panic disorder, sponsored by Massachusetts General Hospital. Primary endpoint: Panic Disorder Severity Scale at 8 weeks. Started Aug 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT00438971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438971.